Mirza International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 18, 2025, 9:53 am

Quick Insight

Mirza International Ltd, a key player in the Leather/Synthetic Products industry, currently trades at a price of 34.0 with a market cap of 472 Cr. The company's financial indicators reveal a P/E ratio, ROE, and ROCE at 0.78%, 1.00%, and 9% respectively, highlighting moderate profitability. With a negative Net Profit of -3, the company faces challenges in generating earnings. The shareholder structure shows strong promoter holding at 71.27%, while institutional ownership by FIIs and DIIs remains minimal. Mirza International's healthy reserves of 537 Cr and manageable borrowings of 48 Cr contribute to a P/BV ratio of 1.07x and an interest coverage ratio of 4.81x, indicating stable financial health. However, the company's Cash Conversion Cycle (CCC) of 140 days warrants closer scrutiny for efficiency improvements. In conclusion, while Mirza International exhibits robust fundamentals in terms of reserves and ownership structure, addressing the negative net profit and optimizing CCC could enhance its overall financial performance.

Competitors of Mirza International Ltd

All Competitor Stocks of Mirza International Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Mirza International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 142.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2025) to 142.00 Cr., marking an increase of 20.00 Cr..
• For Expenses, as of Jun 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 13.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 7.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 9.00%, marking an increase of 4.00%.
• For Other Income, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 19.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 17.00%. The value appears to be increasing, which may not be favorable. It has increased from 6.00% (Mar 2025) to 17.00%, marking an increase of 11.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 22.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.29. The value appears strong and on an upward trend. It has increased from -0.32 (Mar 2025) to 1.29, marking an increase of 1.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:22 pm

Balance Sheet

Last Updated: June 16, 2025, 11:42 am

Below is a detailed analysis of the balance sheet data for Mirza International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 28.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 28.00 Cr..
• For Reserves, as of Mar 2025, the value is 537.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2024) to 537.00 Cr., marking an increase of 12.00 Cr..
• For Borrowings, as of Mar 2025, the value is 48.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 35.00 Cr. (Mar 2024) to 48.00 Cr., marking an increase of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 122.00 Cr.. The value appears to be improving (decreasing). It has decreased from 131.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 734.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 719.00 Cr. (Mar 2024) to 734.00 Cr., marking an increase of 15.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 392.00 Cr. (Mar 2024) to 415.00 Cr., marking an increase of 23.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 308.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 308.00 Cr..
• For Total Assets, as of Mar 2025, the value is 734.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2024) to 734.00 Cr., marking an increase of 15.00 Cr..

Notably, the Reserves (537.00 Cr.) exceed the Borrowings (48.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Mirza International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 5. It has decreased from 1.91 (Mar 23) to 0.87, marking a decrease of 1.04.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 5. It has decreased from 1.91 (Mar 23) to 0.87, marking a decrease of 1.04.
• For Cash EPS (Rs.), as of Mar 24, the value is 2.92. This value is below the healthy minimum of 3. It has decreased from 3.76 (Mar 23) to 2.92, marking a decrease of 0.84.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 39.99. It has increased from 38.60 (Mar 23) to 39.99, marking an increase of 1.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 39.99. It has increased from 38.60 (Mar 23) to 39.99, marking an increase of 1.39.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 45.61. It has decreased from 47.25 (Mar 23) to 45.61, marking a decrease of 1.64.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 4.10. This value is within the healthy range. It has decreased from 5.16 (Mar 23) to 4.10, marking a decrease of 1.06.
• For PBIT / Share (Rs.), as of Mar 24, the value is 2.05. This value is within the healthy range. It has decreased from 3.31 (Mar 23) to 2.05, marking a decrease of 1.26.
• For PBT / Share (Rs.), as of Mar 24, the value is 1.20. This value is within the healthy range. It has decreased from 2.60 (Mar 23) to 1.20, marking a decrease of 1.40.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 23) to 0.87, marking a decrease of 1.04.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 23) to 0.87, marking a decrease of 1.04.
• For PBDIT Margin (%), as of Mar 24, the value is 8.99. This value is below the healthy minimum of 10. It has decreased from 10.92 (Mar 23) to 8.99, marking a decrease of 1.93.
• For PBIT Margin (%), as of Mar 24, the value is 4.50. This value is below the healthy minimum of 10. It has decreased from 7.00 (Mar 23) to 4.50, marking a decrease of 2.50.
• For PBT Margin (%), as of Mar 24, the value is 2.63. This value is below the healthy minimum of 10. It has decreased from 5.50 (Mar 23) to 2.63, marking a decrease of 2.87.
• For Net Profit Margin (%), as of Mar 24, the value is 1.91. This value is below the healthy minimum of 5. It has decreased from 4.04 (Mar 23) to 1.91, marking a decrease of 2.13.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.91. This value is below the healthy minimum of 8. It has decreased from 4.04 (Mar 23) to 1.91, marking a decrease of 2.13.
• For Return on Networth / Equity (%), as of Mar 24, the value is 2.17. This value is below the healthy minimum of 15. It has decreased from 4.95 (Mar 23) to 2.17, marking a decrease of 2.78.
• For Return on Capital Employeed (%), as of Mar 24, the value is 4.82. This value is below the healthy minimum of 10. It has decreased from 7.98 (Mar 23) to 4.82, marking a decrease of 3.16.
• For Return On Assets (%), as of Mar 24, the value is 1.67. This value is below the healthy minimum of 5. It has decreased from 3.62 (Mar 23) to 1.67, marking a decrease of 1.95.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.06. This value is within the healthy range. It has increased from 0.04 (Mar 23) to 0.06, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.87. It has increased from 0.60 (Mar 23) to 0.87, marking an increase of 0.27.
• For Current Ratio (X), as of Mar 24, the value is 2.35. This value is within the healthy range. It has increased from 2.04 (Mar 23) to 2.35, marking an increase of 0.31.
• For Quick Ratio (X), as of Mar 24, the value is 1.16. This value is within the healthy range. It has increased from 1.02 (Mar 23) to 1.16, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.70. This value is below the healthy minimum of 4. It has increased from 0.76 (Mar 23) to 1.70, marking an increase of 0.94.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.81. This value is within the healthy range. It has decreased from 7.28 (Mar 23) to 4.81, marking a decrease of 2.47.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.02. This value is below the healthy minimum of 3. It has decreased from 3.70 (Mar 23) to 2.02, marking a decrease of 1.68.
• For Enterprise Value (Cr.), as of Mar 24, the value is 609.53. It has increased from 494.32 (Mar 23) to 609.53, marking an increase of 115.21.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 23) to 0.96, marking an increase of 0.21.
• For EV / EBITDA (X), as of Mar 24, the value is 10.74. This value is within the healthy range. It has increased from 6.93 (Mar 23) to 10.74, marking an increase of 3.81.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 23) to 0.94, marking an increase of 0.20.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 1.07. This value is within the healthy range. It has increased from 0.90 (Mar 23) to 1.07, marking an increase of 0.17.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 23) to 0.94, marking an increase of 0.20.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness